• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Juniper Networks Shares Are Trading Higher By Over 23%; Here Are 20 Stocks Moving Premarket

    1/9/24 8:23:11 AM ET
    $ARBB
    $BETS
    $CLDI
    $CNEY
    EDP Services
    Technology
    Restaurants
    Consumer Discretionary
    Get the next $ARBB alert in real time by email

    Shares of Juniper Networks, Inc. (NYSE:JNPR) rose sharply in pre-market trading on Tuesday.

    Hewlett Packard Enterprise Co (NYSE:HPE) is reportedly in advanced discussions to acquire networking equipment competitor Juniper Networks.

    Juniper Networks shares climbed 23.3% to $37.26 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Syra Health Corp. (NASDAQ:SYRA) shares rose 56.2% to $1.89 in pre-market trading after jumping 13% on Monday.
    • Notable Labs, Ltd. (NASDAQ:NTBL) shares rose 34.4% to $1.83 in pre-market trading.
    • Galera Therapeutics, Inc. (NASDAQ:GRTX) surged 31.3% to $0.1959 in pre-market trading.
    • SMX (Security Matters) Public Limited Company (NASDAQ:SMX) shares climbed 13% to $0.5310 in pre-market trading after falling 8% on Monday.
    • Calidi Biotherapeutics, Inc. (NASDAQ:CLDI) shares gained 12.2% to $1.75 in pre-market trading after gaining around 7% on Monday. Calidi Biotherapeutics announced the appointment of three new members to its Scientific and Medical Advisory Board.
    • CN Energy Group. Inc. (NASDAQ:CNEY) shares rose 11.6% to $0.0625 in pre-market trading.
    • Top KingWin Ltd (NASDAQ:TCJH) gained 11.1% to $1.30 in pre-market trading after dipping 39% on Monday.
    • ARB IOT Group Limited (NASDAQ:ARBB) gained 10.4% to $1.69 in pre-market trading.
    • MGO Global, Inc. (NASDAQ:MGOL) gained 8% to $0.6339 in pre-market trading after surging 25% on Monday.

    Losers

    • Grifols, S.A. (NASDAQ:GRFS) shares fell 46.3% to $5.98 in pre-market trading.
    • Spectaire Holdings Inc. (NASDAQ:SPEC) shares fell 17.2% to $1.93 in pre-market trading after surging 38% on Monday.
    • Soligenix, Inc. (NASDAQ:SNGX) shares fell 11.3% to $0.8328 in pre-market trading. Soligenix shares gained around 16% on Monday after the company announced that the FDA granted the company's SGX945 development program for the treatment of Behcet's Disease a "Fast-Track" designation.
    • Canoo Inc. (NASDAQ:GOEV) shares fell 11.1% to $0.2240 in pre-market trading. Canoo shares gained around 6% on Monday after the company announced the purchase of manufacturing assets "at dramatically reduced prices" to scale production at its Oklahoma City facility.
    • Bit Brother Limited (NASDAQ:BETS) shares fell 10.7% to $0.0058 in pre-market trading after dipping 15% on Monday. Bit Brother announced a 1-for-1,000 reverse share split.
    • Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) shares fell 10.4% to $2.86 in pre-market trading after jumping 28% on Monday. The company announced it regained compliance with the Nasdaq minimum bid price requirement.
    • Vincerx Pharma, Inc. (NASDAQ:VINC) fell 8.8% to $1.24 in pre-market trading. Vincerx Pharma shares jumped 14% on Monday after the company released clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for relapsed/refractory lymphoma.
    • Hewlett Packard Enterprise Company (NYSE:HPE) fell 8.5% to $16.21 in pre-market trading. HP might be on the verge of acquiring Juniper Networks, in a deal possibly worth around $13 billion. The announcement could be made as early as this week, according to The Wall Street Journal.
    • Zoomcar Holdings, Inc. (NASDAQ:ZCAR) shares declined 8.1% to $3.65 in pre-market trading after falling around 6% on Monday.
    • QuantaSing Group Limited (NASDAQ:QSG) shares fell 8% to $1.84 in pre-market trading after jumping over 27% on Monday.

     

    Now Read This: TD SYNNEX, Albertsons And 3 Stocks To Watch Heading Into Tuesday

    Get the next $ARBB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ARBB
    $BETS
    $CLDI
    $CNEY

    CompanyDatePrice TargetRatingAnalyst
    Hewlett Packard Enterprise Company
    $HPE
    1/13/2026$31.00Buy
    Goldman
    Hewlett Packard Enterprise Company
    $HPE
    11/17/2025Overweight → Equal-Weight
    Morgan Stanley
    Hewlett Packard Enterprise Company
    $HPE
    10/22/2025$24.00Neutral
    Piper Sandler
    Hewlett Packard Enterprise Company
    $HPE
    9/16/2025$24.00Mkt Perform
    Bernstein
    Hewlett Packard Enterprise Company
    $HPE
    8/21/2025$28.00Equal-Weight → Overweight
    Morgan Stanley
    Hewlett Packard Enterprise Company
    $HPE
    7/25/2025$25.00Buy
    Citigroup
    Hewlett Packard Enterprise Company
    $HPE
    7/24/2025$22.00Neutral
    Goldman
    Hewlett Packard Enterprise Company
    $HPE
    7/17/2025$30.00Overweight
    Analyst
    More analyst ratings

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHAIRMAN, CEO AND PRESIDENT Schaber Christopher J bought $20,000 worth of shares (15,132 units at $1.32), increasing direct ownership by 3,993% to 15,511 units (SEC Form 4)

    4 - SOLIGENIX, INC. (0000812796) (Issuer)

    10/3/25 1:18:09 PM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Chief Financial Officer Jackson Andrew C. bought $5,000 worth of shares (2,500 units at $2.00) (SEC Form 4)

    4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)

    8/25/25 8:47:36 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Chief Executive Officer Poma Eric E bought $50,000 worth of shares (25,000 units at $2.00) (SEC Form 4)

    4 - Calidi Biotherapeutics, Inc. (0001855485) (Issuer)

    8/25/25 8:47:39 PM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, Pres GM Networking Rahim Rami exercised 177,858 shares at a strike of $21.37 and covered exercise/tax liability with 88,324 shares (SEC Form 4)

    4 - Hewlett Packard Enterprise Co (0001645590) (Issuer)

    2/24/26 4:29:47 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    CEO Alexander Gregory R. was granted 110,537 units of Restricted Stock Units (SEC Form 4)

    4 - Syra Health Corp (0001922335) (Issuer)

    2/3/26 4:30:22 PM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    EVP & CFO Myers Marie exercised 158,391 shares at a strike of $20.39 and covered exercise/tax liability with 62,706 shares, increasing direct ownership by 47% to 298,337 units (SEC Form 4)

    4 - Hewlett Packard Enterprise Co (0001645590) (Issuer)

    1/22/26 6:46:09 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ARBB
    $BETS
    $CLDI
    $CNEY
    SEC Filings

    View All

    Amendment: SEC Form F-1/A filed by SMX (Security Matters) Public Limited Company

    F-1/A - SMX (Security Matters) Public Ltd Co (0001940674) (Filer)

    2/27/26 5:01:28 PM ET
    $SMX
    Industrial Machinery/Components
    Technology

    SEC Form 6-K filed by Grifols S.A.

    6-K - Grifols SA (0001438569) (Filer)

    2/26/26 4:25:07 PM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form 6-K filed by Grifols S.A.

    6-K - Grifols SA (0001438569) (Filer)

    2/26/26 2:48:42 PM ET
    $GRFS
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman resumed coverage on Hewlett Packard Enterprise with a new price target

    Goldman resumed coverage of Hewlett Packard Enterprise with a rating of Buy and set a new price target of $31.00

    1/13/26 9:16:01 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    Hewlett Packard Enterprise downgraded by Morgan Stanley

    Morgan Stanley downgraded Hewlett Packard Enterprise from Overweight to Equal-Weight

    11/17/25 9:39:59 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    Piper Sandler initiated coverage on Hewlett Packard Enterprise with a new price target

    Piper Sandler initiated coverage of Hewlett Packard Enterprise with a rating of Neutral and set a new price target of $24.00

    10/22/25 7:55:40 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Soligenix Receives Positive Opinion from the European Medicines Agency on the Request for Orphan Drug Designation for SGX945 for the Treatment of Behçet's Disease

    PRINCETON, N.J., Feb. 26, 2026 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that the European Medicines Agency (EMA) Committee for Orphan Medicinal Products (COMP) provided a positive recommendation on the Company's request for orphan drug designation for dusquetide (the active pharmaceutical ingredient in SGX945) for the treatment of Behçet's Disease, following review of the recently published Phase 2a clinical results demonstrating biological efficacy and safety in patients with Behçet's Disease.

    2/26/26 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    HPE Accelerates Service Provider Modernization with AI Infrastructure Innovations at MWC 2026

    Expanded service provider strategy helps HPE customers capitalize on high growth AI opportunities with new network and compute solutions HPE (NYSE:HPE) today unveiled new solutions across networking and compute in advance of Mobile World Congress 2026 that accelerate modernization for service providers. With the new products and enhanced capabilities, HPE's customers can build and operate their own AI infrastructure with low-latency, high-capacity, AI-native solutions from the core to the edge. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260224791368/en/ "AI infrastructure is a critical growth driver for service providers.

    2/24/26 9:00:00 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    Soligenix to Present at BIO Investment & Growth Summit

    PRINCETON, N.J., Feb. 24, 2026 /PRNewswire/ -- Soligenix, Inc. (NASDAQ:SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today that Christopher J. Schaber, Ph.D., President & Chief Executive Officer will deliver a corporate presentation at the BIO Investment & Growth Summit at 3:00 PM on Monday, March 2. The BIO Investment & Growth Summit, held March 2 to 3 at Eden Roc Miami Beach, in Miami Beach, Florida, will include innovative programs, one-on-one meetings, and company presentations. For more information please refer to the conference website at

    2/24/26 7:30:00 AM ET
    $SNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Cyclacel Pharmaceuticals Inc.

    SC 13G/A - Cyclacel Pharmaceuticals, Inc. (0001130166) (Subject)

    11/14/24 7:21:58 PM ET
    $CYCC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Vincerx Pharma Inc.

    SC 13G - Vincerx Pharma, Inc. (0001796129) (Subject)

    11/14/24 3:39:40 PM ET
    $VINC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    SEC Form SC 13G filed by Cyclacel Pharmaceuticals Inc.

    SC 13G - Cyclacel Pharmaceuticals, Inc. (0001130166) (Subject)

    11/14/24 3:27:04 PM ET
    $CYCC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Leadership Updates

    Live Leadership Updates

    View All

    Calidi Biotherapeutics Provides Corporate Update and Key Value Drivers for 2026

    Company intends to file an IND in Q4 2026 for its first RedTail lead candidate, CLD-401, a systemically delivered and targeted genetic medicine engineered to deliver high concentrations of IL-15 superagonist to the tumor microenvironment in patients with metastatic disease.Calidi expects to present proof of concept data demonstrating the versatility of the RedTail platform and expanding its oncology platform with new payloads including the simultaneous delivery of tumor-localized BiTEs alongside T-cell amplifiers.Calidi expects to present proof of concept data demonstrating the applicability of the RedTail platform in non-oncology indications. SAN DIEGO, Jan. 28, 2026 (GLOBE NEWSWIRE) --

    1/28/26 8:00:00 AM ET
    $CLDI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    JFrog Appoints Genefa Murphy as Chief Marketing Officer to Accelerate Its Next Growth Phase

    Company Extends Executive Leadership to Lead the AI-Driven Software Supply Chain Evolution JFrog Ltd. (NASDAQ:FROG), the Liquid Software company, today announced the appointment of Genefa Murphy as Chief Marketing Officer, effective immediately. Murphy brings an expansive resume to JFrog, as a seasoned CMO and go-to-market (GTM) leader with established success in driving global enterprise software growth and strategic business expansion. Coming from software development product management roots and public company GTM leadership, Ms. Murphy also holds a PhD in User Acceptance of New Technology, from the University of Wales and is a veteran of multiple boards of directors in technology and

    1/5/26 8:00:00 AM ET
    $FIVN
    $FROG
    $HPE
    EDP Services
    Technology
    Computer Software: Prepackaged Software
    Retail: Computer Software & Peripheral Equipment

    Syra Health Appoints Healthcare Executive and Former U.S. Marine Gregory R. Alexander as Chief Executive Officer to Drive Growth

    Proven C-Suite Leader with Track Record of Scaling Healthcare Organizations Joins Syra Health to Accelerate Market Expansion and Industry Impact CARMEL, Ind., Dec. 18, 2025 /PRNewswire/ -- Syra Health Corp. (OTCQB:SYRA) ("Syra Health" or the "Company"), a healthcare solutions company dedicated to powering better health outcomes through prevention-focused, accessible, and affordable solutions, announced today the appointment of Gregory R. Alexander as Chief Executive Officer, effective January 5, 2026. Alexander's career has been defined by consistently driving growth and excee

    12/18/25 8:55:00 AM ET
    $SYRA
    Diversified Commercial Services
    Consumer Discretionary

    $ARBB
    $BETS
    $CLDI
    $CNEY
    Financials

    Live finance-specific insights

    View All

    HPE to Present Live Audio Webcast of Fiscal 2026 First Quarter Earnings Conference Call

    HPE (NYSE:HPE) will conduct a live audio webcast of a conference call with analysts to review financial results for the first quarter of fiscal 2026, ending January 31, 2026. The call is scheduled for Monday, March 9, at 4:00 p.m. CT (5:00 p.m. ET), and the webcast will be available at www.hpe.com/investor/2026Q1Webcast. A replay of the webcast will be available at the same website shortly after the call and will remain available for approximately one year. For additional information, see investors.hpe.com. About HPE HPE (NYSE:HPE) is a leader in essential enterprise technology, bringing together the power of AI, cloud, and networking to help organizations achieve more. As pioneers

    2/3/26 7:45:00 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    HPE Reports Fiscal 2025 Fourth Quarter Results

    Posts record quarterly revenue and gross profit; raises FY26 guidance HPE (NYSE:HPE) today announced financial results for the fourth quarter ended October 31, 2025. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251204671507/en/ "HPE finished a transformative year with a strong fourth quarter of profitable growth and disciplined execution," said Antonio Neri, president and CEO of HPE. "During the year, we completed the Juniper Networks acquisition, further scaled our AI and Cloud businesses, and accelerated innovation across our portfolio, giving HPE momentum to advance our strategic priorities in fiscal 2026." "HPE continued

    12/4/25 4:05:00 PM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology

    HPE to Present Live Audio Webcast of Fiscal 2025 Fourth Quarter Earnings Conference Call

    HPE (NYSE:HPE) will conduct a live audio webcast of a conference call with analysts to review financial results for the fourth quarter of fiscal 2025, which ended October 31, 2025. The call is scheduled for Thursday, December 4, at 4:00 p.m. CT (5:00 p.m. ET), and the webcast will be available at http://www.hpe.com/investor/2025Q4Webcast. A replay of the webcast will be available at the same website shortly after the call and will remain available for approximately one year. For additional information, see investors.hpe.com. About HPE HPE (NYSE:HPE) is a leader in essential enterprise technology, bringing together the power of AI, cloud, and networking to help organizations achieve

    11/13/25 7:45:00 AM ET
    $HPE
    Retail: Computer Software & Peripheral Equipment
    Technology